# 510K SUMMARY

# This summary of $5 1 0 ( k )$ safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92

The assigned $5 1 0 ( k )$ number is:

# COMPANY/CONTACT PERSON

Thermo Fisher Scientific Inc   
Seradyn, Inc   
7998 Georgetown Road, Suite 1000   
Indianapolis, IN 46268

Establishment registration No: 1836010

Jack Rogers   
Sr. Manager of Regulatory Affairs   
Telephone: (317) 610-3823   
Fax: (317) 610-0018

DATE PREPARED June 2, 2009

# DEVICE NAME

Trade Name: QMS® Lidocaine Calibrators   
Common Name: Calibrators, Drug Specific   
Device Classification: 21 CFR 862.3200; Clinical Toxicology Calibrator; Class II

# INTENDED USE

The QMS Lidocaine Calibrator set is intended for use in calibration of the QMS Lidocaine assay.

# LEGALLY MARKETED DEVICE TO WHICH EQUIVALENCY IS CLAIMED

Roche Preciset TDM II Calibrators KO31856

DESCRIPTION OF DEVICE

The QMS Lidocaine Calibrator set is a six-level set (0, 0.5, 1.0, 2.5, 5.0, 10 μg/mL) of single analyte (lidocaine) calibrators.

# COMPARISON OF TECHNOLOGICAL CHARACTERISTICS

T Q Lidocaialrators e prepard y quantitativdditn docaie u , a preservatiLidocaine  ded nhe ame quantis ashe predicatemultianalyte aliratr order to achieve a 6-level set of calibrators.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>DeviceQMS Lidocaine Calibrators</td><td rowspan=1 colspan=1>PredicateRoche Preciset TDM II Calibrators</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The QMS Lidocaine Calibrator set isintended for use in calibration of the QMSLidocaine assay.</td><td rowspan=1 colspan=1>The Preciset TDM II Calibrators aredesigned for the calibration of theRoche assays for the quantitativedetermination of digitoxin, amikacin,lidocaine, N-acetylprocainamide,procainamide and quinidine in humanserum and plasma on automatedclinical chemistry analyzers.</td></tr><tr><td rowspan=1 colspan=1>Components</td><td rowspan=1 colspan=1>6-level set of calibrators eachcontaining lidocaine at the followingconcentrations:0, 0.5, 1.0, 2.5, 5.0, 10 μg/mL</td><td rowspan=1 colspan=1>Mixture of 6 different drugs, includinglidocaine at the followingconcentrations:0, 0.5, 1.0, 2.5, 5.0, 10 μg/mL</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Human serum</td><td rowspan=1 colspan=1>Human serum</td></tr></table>

# CONCLUSION

As summarized above, the QMS Lidocaine Calibrators are substantially equivalent to the Roche Preciset TDM I Calibrators.Substantial equivalence has been demonstrated through performance testing to verify that the device functions as intended and that design specifications have been satisfied.

Thermo Fisher Scientific   
c/o Mr. Jack Roger   
Manager Regulatory Affairs   
Seradyn, Inc   
7998 Georgetown Road, Suite 1000   
Indianapolis, IN 46268

# JUL 1.7 2009

Re: k091617 Trade Name: QMS Lidocaine Calibrators Regulation Number: 21 CFR $\ S 8 6 2 . 1 1 5 0$ Regulation Name: Calibrators Regulatory Class: Class II Product Codes: DLJ Dated: June 02, 2009 Received: June 03, 2009

Dear Mr. Roger:

We have reviewed your Section 510(k) premarket notification ofintent to market the device referenced above an haveeihe vi tntly euivalent r e its oru tatnhe to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and CosmeticAct (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act.The eneral controls provisios of the Act include requirements r annual registatn, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

Iyur devic  clasabove)into eithrclass  SpecilControl)or cass II MA), it y e subje o such aditial controls.Exiting major regulatins affecting your evice can be found inTit, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advis that FDA's issuanceoa substantial equivalence etermination does not mean hat FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ( 301 ) 796-5680 or at its Internet address '3 http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

GC.H

Courtney C. Harper, Ph.D.   
Acting Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) N (f known): $k 0 9 1 6 1 7$

Device Name: QMS® Lidocaine Calibrators

# Indications for Use:

.The QMS Lidocaine Calibrator set is intended for use in calibration of the QMS Lidocaine assay.

Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)

![](images/8c005414dc8e38033fa87833c9a2bfc0debcafcb2ccf07b92f8ee3a4a855573a.jpg)

Diyision Sign-Off . Office of In Vitro Diagnostic Device Evaluation and Safety

510(k) k091617